LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 538 | 3673 | 0.1464 | -0.3367 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 72 | hr | 1097 | 540 | 3673 | 0.1470 | -0.3343 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 540 | 3673 | 0.1468 | -0.3382 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 540 | 3761 | 0.1437 | -0.0755 |
MDA-MB-231 | Geldanamycin | 10 | uM | LJP5 | 72 | hr | 1235 | 541 | 4660 | 0.1163 | -0.3517 |
MDA-MB-231 | JNK-9L | 10 | uM | LJP6 | 72 | hr | 1235 | 541 | 4405 | 0.1230 | -0.3626 |
Hs 578T | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 658 | 542 | 3761 | 0.1444 | -0.0741 |
Hs 578T | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 658 | 548 | 3761 | 0.1457 | -0.0704 |
MDA-MB-231 | WZ-4-145 | 10 | uM | LJP6 | 72 | hr | 1235 | 552 | 4405 | 0.1252 | -0.3563 |
MCF 10A | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 962 | 552 | 10692 | 0.0517 | -0.1484 |
MDA-MB-231 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 554 | 4405 | 0.1259 | -0.3546 |
Hs 578T | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 658 | 554 | 3933 | 0.1408 | -0.0671 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 556 | 3933 | 0.1414 | -0.0638 |
SK-BR-3 | LDN-193189 | 10 | uM | LJP5 | 72 | hr | 1401 | 557 | 4245 | 0.1286 | -0.4568 |
Hs 578T | Momelotinib | 10 | uM | LJP5 | 72 | hr | 658 | 561 | 3933 | 0.1426 | -0.0610 |
MDA-MB-231 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1235 | 562 | 4405 | 0.1271 | -0.3529 |
Hs 578T | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 658 | 562 | 3761 | 0.1496 | -0.0609 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 566 | 4203 | 0.1350 | -0.3455 |
Hs 578T | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 658 | 566 | 3933 | 0.1440 | -0.0571 |
BT-20 | Withaferin A | 10 | uM | LJP6 | 72 | hr | 1097 | 566 | 3673 | 0.1542 | -0.3158 |
Hs 578T | Y39983 | 10 | uM | LJP6 | 72 | hr | 658 | 567 | 3761 | 0.1510 | -0.0578 |
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 567 | 3933 | 0.1442 | -0.0560 |
MCF7 | CGP60474 | 10 | uM | LJP5 | 72 | hr | 1209 | 568 | 4203 | 0.1357 | -0.3435 |
Hs 578T | PF562271 | 10 | uM | LJP6 | 72 | hr | 658 | 568 | 3761 | 0.1511 | -0.0577 |
Hs 578T | Neratinib | 10 | uM | LJP5 | 72 | hr | 658 | 568 | 3933 | 0.1445 | -0.0559 |